Neurologische Komplikationen in der Anästhesiologie – Teil I – Schlaganfall, Visusverlust, zentral anticholinerges Syndrom

Zusammenfassung

Neurologische Komplikationen nach Allgemein- und Regionalanästhesien verschlechtern das postoperative Outcome der Patienten, führen durch zusätzliche und erweiterte Diagnostik sowie eine längere Hospitalisationsdauer zu steigenden Kosten und beeinflussen die Patientenzufriedenheit nachhaltig. Die Inzidenz neurologischer Komplikationen kann durch gezielte Präventionsmaßnahmen und ein optimales anästhesiologisches Management reduziert werden. Eine rasche interdisziplinäre Zusammenarbeit bei auftretenden neurologischen Komplikationen ist für Diagnose und Therapie entscheidend und kann Patienten vor dauerhaften Schäden bewahren. Der vorliegende Artikel behandelt schwerpunktmäßig wichtige zentrale neurologische Komplikationen nach einer Allgemeinanästhesie. Der perioperative Schlaganfall (POS) und der postoperative Visusverlust (POVL) zählen zu schweren Komplikationen mit zum Teil fatalen Verläufen. Das zentral anticholinerge Syndrom (ZAS) ist ein inzwischen rares Ereignis, dessen Symptomatik und Therapie jedoch jedem Anästhesisten bekannt sein sollten.

Abstract

Neurological complications following anesthesia deteriorate patients' outcome, and increase hospital costs because of prolonged hospitalization and supplemental medical care. Moreover, patients' satisfaction is negatively influenced by neurological sequelae after anesthesia.

Improving anesthesiologic management based on consequent prevention measures can help to reduce the incidence of neurological complications after anesthesia. In case of neurological complications in the perioperative phase an interdisciplinary approach in immediate diagnosis and treatment may prevent patients from permanent damage. The present review article gives an overview over incidences, diagnostic and therapeutic issues of neurologic complications in operative patients, such as perioperative stroke, postoperative visual loss and the anticholinergic syndrome.

neurologische Komplikationen - perioperativer Schlaganfall - perioperativer Visusverlust - zentral anticholinerges Syndom

neurologic complications - perioperative stroke - postoperative visual loss - anticholingeric syndrom

Kernaussagen

• Thromboembolisch ischämische Ereignisse sind die häufigste Ursache für einen perioperativen Schlaganfall.

• Die rasch erfolgende intraarterielle Lyse und / oder transarterielle Embolektomie kann eine therapeutische Option in der Behandlung eines perioperativen Schlaganfalls darstellen.

• Anästhesiologische Manipulationen am Hals, hypotone Kreislaufsituationen sowie die Patientenlagerung sollten ständig kritisch in Bezug auf die mögliche Verursachung eines Schlaganfalls geprüft werden.

• Die Empfehlungen der ASA-Task-Force zur Verhinderung von POVL sollten berücksichtigt werden.

• Bei Auftreten von postoperativen Visusstörungen muss eine sofortige ophthalmologische und neurologische Befunderhebung erfolgen.

• Das zentral anticholinerge Syndrom ist in der modernen Anästhesie eine eher seltene Komplikation und kann durch Gabe von Physostigmin effektiv behandelt werden.

Literatur

• 1 Radtke FM, Spies C.. Nur nicht den Kopf verlieren!.  Anasthesiol Intensivmed Notfallmed Schmerzther. 2010;  45 104-105
• 2 Lutz A, Heymann A, Radtke FM, Spies CD.. If delirium is not monitored it will often be not detected.  Anasthesiol Intensivmed Notfallmed Schmerzther. 2010;  45 106-111
• 3 Heymann A, Spies C.. Prevention and therapy.  Anasthesiol Intensivmed Notfallmed Schmerzther. 2010;  45 112-116
• 4 Gunther U, Putensen C.. How to assess delirium in mechanically ventilated patients.  Anasthesiol Intensivmed Notfallmed Schmerzther. 2010;  45 118-122
• 5 Kam PC, Calcroft RM.. Peri-operative stroke in general surgical patients.  Anaesthesia. 1997;  52 879-883
• 6 Parikh S, Cohen JR.. Perioperative stroke after general surgical procedures.  N Y State J Med. 1993;  93 162-165
• 7 Likosky DS, Marrin CA, Caplan LR et al.. Determination of etiologic mechanisms of strokes secondary to coronary artery bypass graft surgery.  Stroke. 2003;  34 2830-2834
• 8 Bucerius J, Gummert JF, Borger MA et al.. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients.  Ann Thorac Surg. 2003;  75 472-478
• 9 Bateman BT, Schumacher HC, Wang S, Shaefi S, Berman MF.. Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors, and outcomes.  Anesthesiology. 2009;  110 231-238
• 10 Bond R, Rerkasem K, Shearman CP, Rothwell PM.. Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis.  Cerebrovasc Dis. 2004;  18 37-46
• 11 McKhann GM, Grega MA, Borowicz Jr. LM, Baumgartner WA, Selnes OA.. Stroke and encephalopathy after cardiac surgery: an update.  Stroke. 2006;  37 562-571
• 12 Selim M.. Perioperative stroke.  N Engl J Med. 2007;  356 706-713
• 13 Rees K, Beranek-Stanley M, Burke M, Ebrahim S.. Hypothermia to reduce neurological damage following coronary artery bypass surgery.  Cochrane Database Syst Rev. CD 002138 2001; 
• 14 Likosky DS, Leavitt BJ, Marrin CA et al.. Intra- and postoperative predictors of stroke after coronary artery bypass grafting.  Ann Thorac Surg. 2003;  76
• 15 Blacker DJ, Flemming KD, Link MJ, Brown Jr. RD. The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery.  Mayo Clin Proc. 2004;  79 223-229
• 16 Reuber M, Dunkley LA, Turton EP, Bell MD, Bamford JM.. Stroke after internal jugular venous cannulation.  Acta Neurol Scand. 2002;  105 235-239
• 17 Dixon B, Santamaria J, Campbell D.. Coagulation activation and organ dysfunction following cardiac surgery.  Chest. 2005;  128 229-236
• 18 Paramo JA, Rifon J, Llorens R et al.. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.  Haemostasis. 1991;  21 58-64
• 19 Hinterhuber G, Bohler K, Kittler H, Quehenberger P.. Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia.  Dermatol Surg. 2006;  32 632-639
• 20 Gottesman RF, Sherman PM, Grega MA et al.. Watershed strokes after cardiac surgery: diagnosis, etiology, and outcome.  Stroke. 2006;  37 2306-2311
• 21 Pohl A, Cullen DJ.. Cerebral ischemia during shoulder surgery in the upright position: a case series.  J Clin Anesth. 2005;  17 463-469
• 22 Weintraub MI, Khoury A.. Cerebral hemodynamic changes induced by simulated tracheal intubation: a possible role in perioperative stroke? Magnetic resonance angiography and flow analysis in 160 cases.  Stroke. 1998;  29 1644-1649
• 23 Menon U, Kenner M, Kelley RE.. Perioperative stroke.  Expert Rev Neurother. 2007;  7 1003-1011
• 24 Ropper AH, Wechsler LR, Wilson LS.. Carotid bruit and the risk of stroke in elective surgery.  N Engl J Med. 1982;  307 1388-1390
• 25 Naylor AR, Mehta Z, Rothwell PM, Bell PR.. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature.  Eur J Vasc Endovasc Surg. 2002;  23 283-294
• 26 Szeder V, Torbey MT.. Prevention and treatment of perioperative stroke.  Neurologist. 2008;  14 30-36
• 27 Dunn AS, Turpie AG.. Perioperative management of patients receiving oral anticoagulants: a systematic review.  Arch Intern Med. 2003;  163 901-908
• 28 Fleming MD, Stone WM, Scott P et al.. Safety of carotid endarterectomy in patients concurrently on clopidogrel.  Ann Vasc Surg. 2009;  23 612-615
• 29 Devereaux PJ, Yang H, Yusuf S et al.. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.  Lancet. 2008;  371 1839-1847
• 30 Bangalore S, Wetterslev J, Pranesh S et al.. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis.  Lancet. 2008;  372 1962-1976
• 31 Durazzo AE, Machado FS, Ikeoka DT et al.. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial.  J Vasc Surg. 2004;  39 975-966
• 32 McGirt MJ, Perler BA, Brooke BS et al.. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy.  J Vasc Surg. 2005;  42 836-827
• 33 Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P.. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).  Chest. 2008;  133
• 34 Charlson ME, MacKenzie CR, Gold JP et al.. Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications?.  Ann Surg. 1990;  212 567-580
• 35 Gandhi GY, Nuttall GA, Abel MD et al.. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients.  Mayo Clin Proc. 2005;  80 862-866
• 36 Akhtar S, Barash PG, Inzucchi SE.. Scientific principles and clinical implications of perioperative glucose regulation and control.  Anesth Analg. 2010;  110 478-497
• 37 Wikholm G.. Transarterial embolectomy in acute stroke.  AJNR Am J Neuroradiol. 2003;  24 892-894
• 38 Kerber CW, Barr JD, Berger RM, Chopko BW.. Snare retrieval of intracranial thrombus in patients with acute stroke.  J Vasc Interv Radiol. 2002;  13 1269-1274
• 39 Moazami N, Smedira NG, McCarthy PM et al.. Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation.  Ann Thorac Surg. 2001;  72 1937-1939
• 40 Fukuda I, Gomi S, Meguro K, Wada M.. Impact of immediate cerebral angiography for in-hospital cerebral thromboembolism after cardiovascular surgery.  Jpn J Thorac Cardiovasc Surg. 2001;  49 282-286
• 41 Roth S.. Postoperative visual loss.. New York: Elsevier; 2010: 2821-2841
• 42 Torossian A, Schmidt J, Schaffartzik W, Wulf H.. Loss of vision after non-ophthalmic surgery: systematic review of the literature on incidence, pathogenesis, treatment and prevention.  Anaesthesist. 2006;  55 457-464
• 43 Roth S, Thisted RA, Erickson JP, Black S, Schreider BD.. Eye injuries after nonocular surgery. A study of 60,965 anesthetics from 1988 to 1992.  Anesthesiology. 1996;  85 1020-1027
• 44 Warner ME, Warner MA, Garrity JA, MacKenzie RA, Warner DO.. The frequency of perioperative vision loss.  Anesth Analg. 2001;  93
• 45 Nuttall GA, Garrity JA, Dearani JA et al.. Risk factors for ischemic optic neuropathy after cardiopulmonary bypass: a matched case/control study.  Anesth Analg. 2001;  93
• 46 Chang SH, Miller NR.. The incidence of vision loss due to perioperative ischemic optic neuropathy associated with spine surgery: the Johns Hopkins Hospital Experience.  Spine (Phila Pa 1976). 2005;  30 1299-1302
• 47 Shen Y, Drum M, Roth S.. The prevalence of perioperative visual loss in the United States: a 10-year study from 1996 to 2005 of spinal, orthopedic, cardiac, and general surgery.  Anesth Analg. 2009;  109 1534-1545
• 48 Williams EL, Hart Jr. WM, Tempelhoff R.. Postoperative ischemic optic neuropathy.  Anesth Analg. 1995;  80 1018-1029
• 49 Lee LA, Roth S, Posner KL et al.. The American Society of Anesthesiologists Postoperative Visual Loss Registry: analysis of 93 spine surgery cases with postoperative visual loss.  Anesthesiology. 2006;  105 867-658
• 50 Sweeney PJ, Breuer AC, Selhorst JB et al.. Ischemic optic neuropathy: a complication of cardiopulmonary bypass surgery.  Neurology. 1982;  32 560-562
• 51 Newman NJ.. Perioperative visual loss after nonocular surgeries.  Am J Ophthalmol. 2008;  145 604-610
• 52 Grant GP, Szirth BC, Bennett HL et al.. Effects of prone and reverse trendelenburg positioning on ocular parameters.  Anesthesiology. 2010;  112 57-65
• 53 Practice advisory for perioperative visual loss associated with spine surgery: a report by the American Society of Anesthesiologists Task Force on Perioperative Blindness.  Anesthesiology. 2006;  104 1319-1328
• 54 Forrer GR, Miller JJ.. Atropine coma: a somatic therapy in psychiatry.  Am J Psychiatry. 1958;  115 455-458
• 55 Senne I, Zourelidis C, Irnich D et al.. Central anticholinergic syndrome and apnea after general anaesthesia. A rare manifestation of the central anticholinergic syndrome.  Anaesthesist. 2003;  52 608-611
• 56 Renner UD, Oertel R, Kirch W.. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.  Ther Drug Monit. 2005;  27 655-665
• 57 Hochreuther S.. Central anticholinergic syndrome.  Intensivmed. 2009;  1-3
• 58 Nietgen GW, Honemann CW, Chan CK, Kamatchi GL, Durieux ME.. Volatile anaesthetics have differential effects on recombinant m1 and m3 muscarinic acetylcholine receptor function.  Br J Anaesth. 1998;  81 569-577
• 59 Meuret P, Backman SB, Bonhomme V, Plourde G, Fiset P.. Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers.  Anesthesiology. 2000;  93 708-717
• 60 Kaiser-Stadler M, Altmayer P.. Central anticholinergic syndrome after propofol anesthesia.  Anasthesiol Intensivmed Notfallmed Schmerzther. 1995;  30 116-117
• 61 Flood P, Ramirez-Latorre J, Role L.. Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected.  Anesthesiology. 1997;  86 859-865
• 62 Fassoulaki A, Sarantopoulos C, Derveniotis C.. Physostigmine increases the dose of propofol required to induce anaesthesia.  Can J Anaesth. 1997;  44 1148-1151
• 63 Durieux ME.. Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications.  Anesthesiology. 1996;  84 173-189
• 64 Anderson JA.. Reversal agents in sedation and anesthesia: a review.  Anesth Prog. 1988;  35 43-47
• 65 Brown DV, Heller F, Barkin R.. Anticholinergic syndrome after anesthesia: a case report and review.  Am J Ther. 2004;  11 144-153
• 66 Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE.. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.  Ann Emerg Med. 2000;  35 374-381
• 67 Granacher RP, Baldessarini RJ.. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.  Arch Gen Psychiatry. 1975;  32 375-380
• 68 Rupreht J.. The central muscarinic transmission during anaesthesia and recovery –the central anticholinergic syndrome.  Anaesthesiol Reanim. 1991;  16 250-258
• 69 Schneck HJ, Rupreht J.. Central anticholinergic syndrome (CAS) in anesthesia and intensive care.  Acta Anaesthesiol Belg. 1989;  40 219-228
• 70 Holzgrafe RE, Vondrell JJ, Mintz SM.. Reversal of postoperative reactions to scopolamine with physostigmine.  Anesth Analg. 1973;  52 921-925